Evaluation and management of Non-variceal upper gastrointestinal bleeding

R Samuel, M Bilal, O Tayyem, P Guturu - Disease-a-month, 2018‏ - Elsevier
Non-variceal upper gastrointestinal bleeding continues to be an important cause of
morbidity and mortality. The most common causes include peptic ulcer disease, Mallory …

Risk of major gastrointestinal bleeding with new vs conventional oral anticoagulants: a systematic review and meta-analysis

ZC Gu, AH Wei, C Zhang, XH Wang, L Zhang… - Clinical …, 2020‏ - Elsevier
Background & Aims There is controversy over whether use of non-vitamin K antagonist oral
anticoagulants (NOACs) associates with increased risk of major gastrointestinal bleeding …

Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: A nationwide propensity score–weighted study

AB Ingason, JP Hreinsson, AS Ágústsson… - Annals of Internal …, 2021‏ - acpjournals.org
Background: Gastrointestinal bleeding (GIB) rates for direct oral anticoagulants (DOACs)
and warfarin have been extensively compared. However, population-based studies …

Mortality rate and risk factors for gastrointestinal bleeding in elderly patients

MV Lenti, L Pasina, S Cococcia, L Cortesi… - European journal of …, 2019‏ - Elsevier
Background Gastrointestinal bleeding (GIB) is burdened by high mortality rate that increases
with aging. Elderly patients may be exposed to multiple risk factors for GIB. We aimed at …

Risk of gastrointestinal bleeding during anticoagulant treatment

A Lanas-Gimeno, A Lanas - Expert opinion on drug safety, 2017‏ - Taylor & Francis
Introduction: Gastrointestinal bleeding (GIB) is a major problem in patients on oral
anticoagulation therapy. This issue has become even more pressing since the introduction …

Gastrointestinal bleeding risk with direct oral anticoagulants

R Benamouzig, M Guenoun, D Deutsch… - … Drugs and Therapy, 2022‏ - Springer
Purpose Although direct oral anticoagulants (DOACs) are associated with an overall
favourable safety profile, the risk of gastrointestinal bleeding with DOACs compared with …

A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: a comparison of efficacy and safety following treatment with direct oral …

AT Cohen, NR Hill, X Luo… - International …, 2018‏ - internationaljournalofcardiology.com
Abstract Background Direct oral anticoagulants (DOACs) are indicated for the prevention of
stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation. While no …

[HTML][HTML] Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease

M Wu, T **a, Y Li, T Wang, S Yang, J Yu… - Asian journal of …, 2022‏ - Elsevier
Cardiovascular disease is the leading cause of global mortality, with anticoagulant therapy
being the main prevention and treatment strategy. Recombinant hirudin (r-hirudin) is a direct …

Do proton pump inhibitors reduce upper gastrointestinal bleeding in older patients with atrial fibrillation treated with oral anticoagulants? A nationwide cohort study in …

S Drusch, A Neumann, H Michelon, M Pépin, M Zureik… - Drugs & Aging, 2024‏ - Springer
Abstract Background Proton pump inhibitors (PPIs) are largely used in older adults and data
are needed in off-label indications, such as the prevention of upper gastrointestinal bleeding …

Differences in gastrointestinal safety profiles among novel oral anticoagulants: Evidence from a network meta-analysis

WQ Guo, XH Chen, XY Tian, L Li - Clinical Epidemiology, 2019‏ - Taylor & Francis
Background There is no consensus at present regarding the differences in the risk of GI
bleeding across various NOAC regimens. Therefore, we performed a network meta-analysis …